Browse treatment
ACAT inhibition
agents to slow down human AAA-expansion
All mecanism
alpha-glucosidase inhibitors
angiotensin-Converting Enzyme Inhibitors
angiotensin-receptor blockers
anti hypertensive agent
anti inflammatory drugs
anti-anginal drugs
antiarrythmic drugs
antibiotics
anticoagulant
antidiabetic drugs
antioxydants
antiplatelets drug
antithrombotics
beta-blockers
BNP-guided management
calcium channel blockers
catheter ablation
catheter ablation of ventricular tachycardia
caval filter
cell-based therapies
CEPT inhibition
cholesterol lowering intervention
complement inhibition
diigitalis glycosides
diiuretics
direct antithrombins
direct factor Xa inhibitors
embolic protection
endarterectomy
endovascular treatment
Exercise Therapy
fibrinolysis
glitazone
glucose insulin potassium
graduated compression stockings
heparin (UFH or LMWH)
HR modifiers
ICD
increasing hemoglobin concentration
inhibition of the renin-angiotensin system (ACEI or ARB)
insulin secretagogues
insulin sensitizer
intensive glycemic control
Intravascular Brachytherapy
Late revascularisation
LMWH
Miscellaneous
multiple risk factor interventions
myocardial revascularization
new drug under development
new oral anticoagulant
niacin
nitrates
off-pump CABG
omega-3 fatty acids
pacemaker
PCI
pentasaccharide
percutaneous left ventricular assist devices
phosphodiesterase III inhibitors
plasma homocysteine lowering intervention
pre treatment for PCI
preconditioning
prevention
primary prevention of sudden death
proton-pump inhibitors
radial access
relaxine
renin inhibitor
restenosis prevention
resynchronization (CRT) - defibrillators (ICD)
revascularization with drug eluting stent
rythm control
screening for CAD
sefibrillation
spinal cord stimulation
statin
strategy
surgery
thrombectomy
transmyocardial revacularization
UFH
vasodilators therapy
vasopeptidase inhibitor
vasopressin
vasopressin antagonist
vein grafts pretreatment
|